These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17691481)

  • 21. Oxidatively induced DNA damage and its repair in cancer.
    Dizdaroglu M
    Mutat Res Rev Mutat Res; 2015; 763():212-45. PubMed ID: 25795122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy.
    Xu Y; Her C
    Biomolecules; 2015 Jul; 5(3):1652-70. PubMed ID: 26287259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.
    Srinivasan A; Gold B
    Future Med Chem; 2012 Jun; 4(9):1093-111. PubMed ID: 22709253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer.
    Blasiak J; Arabski M; Krupa R; Wozniak K; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Zadrozny M
    Mutat Res; 2004 Oct; 554(1-2):139-48. PubMed ID: 15450412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies.
    Mantso T; Goussetis G; Franco R; Botaitis S; Pappa A; Panayiotidis M
    Semin Cancer Biol; 2016 Jun; 37-38():96-105. PubMed ID: 27025900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the DNA damage response for cancer therapy.
    Powell SN; Bindra RS
    DNA Repair (Amst); 2009 Sep; 8(9):1153-65. PubMed ID: 19501553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.
    Skvortsov S; Debbage P; Lukas P; Skvortsova I
    Semin Cancer Biol; 2015 Apr; 31():36-42. PubMed ID: 24954010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting DNA repair defects for novel cancer therapies.
    van Gent DC; Kanaar R
    Mol Biol Cell; 2016 Jul; 27(14):2145-8. PubMed ID: 27418635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
    Bolderson E; Richard DJ; Zhou BB; Khanna KK
    Clin Cancer Res; 2009 Oct; 15(20):6314-20. PubMed ID: 19808869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon.
    Nikitaki Z; Michalopoulos I; Georgakilas AG
    Future Med Chem; 2015 Aug; 7(12):1543-58. PubMed ID: 26306465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells: are they responsible for treatment failure?
    Maugeri-Saccà M; Vici P; Di Lauro L; Barba M; Amoreo CA; Gallo E; Mottolese M; De Maria R
    Future Oncol; 2014 Oct; 10(13):2033-44. PubMed ID: 25396775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Checkpoint control and cancer.
    Medema RH; Macůrek L
    Oncogene; 2012 May; 31(21):2601-13. PubMed ID: 21963855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting base excision repair as a sensitization strategy in radiotherapy.
    Vens C; Begg AC
    Semin Radiat Oncol; 2010 Oct; 20(4):241-9. PubMed ID: 20832016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA Repair Endonucleases: Physiological Roles and Potential as Drug Targets.
    Doherty R; Madhusudan S
    J Biomol Screen; 2015 Aug; 20(7):829-41. PubMed ID: 25877151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.
    Gossage L; Madhusudan S
    Mol Diagn Ther; 2007; 11(6):361-80. PubMed ID: 18078354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting homologous recombination repair defects in cancer.
    Evers B; Helleday T; Jonkers J
    Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA Damaging Agents in Chemical Biology and Cancer.
    Sauter B; Gillingham D
    Chimia (Aarau); 2020 Sep; 74(9):693-698. PubMed ID: 32958106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling DNA Repair Pathways: Recent Advances and Future Directions.
    Gentile F; Tuszynski JA; Barakat KH
    Curr Pharm Des; 2016; 22(23):3527-46. PubMed ID: 27093954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair: from genome maintenance to biomarker and therapeutic target.
    Jalal S; Earley JN; Turchi JJ
    Clin Cancer Res; 2011 Nov; 17(22):6973-84. PubMed ID: 21908578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair pathways as targets for cancer therapy.
    Helleday T; Petermann E; Lundin C; Hodgson B; Sharma RA
    Nat Rev Cancer; 2008 Mar; 8(3):193-204. PubMed ID: 18256616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.